The adaptor and signaling proteins TRAF2, TRAF3, cIAP1 and cIAP2 may inhibit alternative nuclear factor-jB (NF-jB) signaling in resting cells by targeting NF-jB-inducing kinase (NIK) for ubiquitin-dependent degradation, thus preventing processing of the NF-jB2 precursor protein p100 to release p52. However, the respective functions of TRAF2 and TRAF3 in NIK degradation and activation of alternative NF-jB signaling have remained elusive. We now show that CD40 or BAFF receptor activation result in TRAF3 degradation in a cIAP1-cIAP2-and TRAF2-dependent way owing to enhanced cIAP1, cIAP2 TRAF3-directed ubiquitin ligase activity. Receptor-induced activation of cIAP1 and cIAP2 correlated with their K63-linked ubiquitination by TRAF2. Degradation of TRAF3 prevented association of NIK with the cIAP1-cIAP2-TRAF2 ubiquitin ligase complex, which resulted in NIK stabilization and NF-jB2-p100 processing. Constitutive activation of this pathway causes perinatal lethality and lymphoid defects.
The adaptor and signaling proteins TRAF2, TRAF3, cIAP1 and cIAP2 may inhibit alternative nuclear factor-jB (NF-jB) signaling in resting cells by targeting NF-jB-inducing kinase (NIK) for ubiquitin-dependent degradation, thus preventing processing of the NF-jB2 precursor protein p100 to release p52. However, the respective functions of TRAF2 and TRAF3 in NIK degradation and activation of alternative NF-jB signaling have remained elusive. We now show that CD40 or BAFF receptor activation result in TRAF3 degradation in a cIAP1-cIAP2-and TRAF2-dependent way owing to enhanced cIAP1, cIAP2 TRAF3-directed ubiquitin ligase activity. Receptor-induced activation of cIAP1 and cIAP2 correlated with their K63-linked ubiquitination by TRAF2. Degradation of TRAF3 prevented association of NIK with the cIAP1-cIAP2-TRAF2 ubiquitin ligase complex, which resulted in NIK stabilization and NF-jB2-p100 processing. Constitutive activation of this pathway causes perinatal lethality and lymphoid defects.
The mammalian Rel-NF-kB family of transcription factors are important in innate and adaptive immune responses, inflammation, cell survival, and cancer 1, 2 . In resting cells, inhibitory IkB molecules bind NF-kB (A002937) dimers by means of ankyrin repeats and retain them in the cytoplasm 1 . The IkB kinase (IKK) complex, comprised of the catalytic subunits IKKa and IKKb and the regulatory subunit IKKg (NEMO), controls NF-kB activation by phosphorylating IkBs and targeting them to Lys48-linked polyubiquitination by the ubiquitin ligase (E3) SCF IkB , thereby inducing IkB proteasomal degradation 3 . This pathway, known as the classical or canonical NF-kB signaling pathway, mostly affects p50-RelA and p50-c-Rel heterodimers 1 . However, the Nfkb2 gene product p100, which contains IkB-like ankyrin repeats in its C-terminal region, is regulated through the alternative or noncanonical NF-kB signaling pathway 4 . In this pathway, p100, which is mainly associated with RelB in unstimulated cells 1 , is phosphorylated by IKKa at its C-terminal region 4 , also leading to Lys48-linked polyubiquitination by the SCF IkB complex 5 . In this case, however, Lys48-linked polyubiquitination results in limited proteolysis of the C-terminal ankyrin repeats and release of the N-terminal p52 protein subunit, which then forms heterodimers with RelB (p52-RelB) 6 . This alternative pathway is activated by lymphorganogenic cytokines, such as lymphotoxin-a-b heterotrimers, and B cell survival and maturation factors, such as CD40 ligand (CD40L) and BAFF [7] [8] [9] [10] . An important component of this pathway is the protein kinase NIK (A001654, encoded by Map3k14) which activates IKKa 4, 6, 8 .
Lymphotoxin-a-b, CD40L and BAFF belong to the tumor necrosis factor (TNF) superfamily, whose members signal through trimeric receptors (TNF receptors or TNFRs) and signaling proteins called TNFR-associated factors (TRAFs) 11, 12 that are key intermediates in both the classical and alternative NF-kB signaling pathways 12, 13 . The TRAFs share a C-terminal TRAF domain that mediates oligomerization as well as receptor binding, and a variable number of zinc fingers within their N-terminal portions 11, 14 . TRAF2 (A002308)-TRAF6 also contain an N-terminal RING finger that is critical for E3 activity, which catalyzes formation of nondegradative Lys63-linked polyubiquitin chains 13 , a function demonstrated most clearly for TRAF2 (ref. 15 ) and TRAF6 (ref. 16 ). In the context of TNFR1-activated classical NF-kB signaling, TRAF2 and TRAF5 act redundantly 17 , but the exact targets for their E3 activity remain contentious 12 . TRAF2 and TRAF6 are both involved in CD40-induced classical NF-kB activation 11, 18 , and TRAF6 is a critical mediator of NF-kB signaling downstream of Toll-like and interleukin-1 receptors 19 . Although some of these receptors, such as TLR4, engage TRAF3 (A002309) to activate interferon signaling, TRAF3 does not directly contribute to classical NF-kB signaling 20 . TRAF2, TRAF5 and TRAF6 also activate NF-kB signaling upon overexpression 11, 21, 22 , an activity not shown by TRAF3 (ref. 20) . Recently, TRAF3 was found to act as a negative regulator of TRAF2-and TRAF6-dependent mitogen-activated protein kinase (MAPK) activation 23 . These results strongly suggest that TRAF2 and TRAF3 have distinct signaling functions and activities.
Notably, whereas TRAF2 ablation in B cells attenuates classical NF-kB signaling, it constitutively activates the alternative pathway 24 . A similar phenotype is seen upon TRAF3 ablation, although TRAF3 does not directly affect classical NF-kB signaling 25 . Based on constitutive NF-kB2-p100 processing and presence of nuclear p52-RelB in TRAF2-or TRAF3-deficient cells, both molecules were described as ''inhibitors'' of alternative NF-kB signaling 26 . Activation of the alternative pathway was suggested to depend on receptorinduced TRAF3 degradation and stabilization of NIK 27 . However, ablation of TRAF2 also results in NIK accumulation 28 . Because TRAF2 is an E3 ligase and TRAF3 is similar in structure to TRAF2, it was assumed that both TRAFs target NIK to ubiquitin-dependent proteasomal degradation in unstimulated cells [26] [27] [28] . However, the finding of activated alternative NF-kB signaling upon ablation of either TRAF2 or TRAF3 suggests that each of these molecules has a unique function that is not provided by the remaining family member.
The critical role of TRAF3 in NIK protein turnover is underscored by identification of TRAF3 mutations in human multiple myeloma that elevate NIK expression and activate p100 processing 29, 30 . Deregulated alternative NF-kB signaling also accounts for the postnatal lethality associated with TRAF3 ablation 25 . We noted that Traf2 À/À mice, which also die perinatally 31 , resemble Traf3 À/À mice 32 , and therefore we began to investigate the relative functions of these TRAFs in alternative NF-kB signaling. In particular, we became interested in the relationships between TRAF2 and TRAF3 and two other RINGcontaining components of the alternative pathway, cIAP1 and cIAP2, which belong to the IAP (inhibitors of apoptosis) family, characterized by presence of one or more BIR domains [28] [29] [30] 33, 34 . Many IAPs have antiapoptotic functions, but their mechanisms of action are diverse 33 . The antiapoptotic function of cIAP1 and cIAP2 is inhibited upon release of mitochondrial protein Diablo (SMAC), which may serve both as an activator and a substrate of the E3 activity of these cIAPs 35 . Accordingly, Diablo mimics that bind to the same sites on cIAP1 and cIAP2 as does Diablo induce cIAP1 and cIAP2 self-ubiquitination and proteasomal degradation, and stabilization of NIK 28, 34, 36 , leading to the conclusion that cIAP1 and cIAP2 are required for NIK turnover 28, 34 . This possibility is supported by the finding that in multiple myeloma, in which the linked genes encoding cIAP1 (BIRC2) and cIAP2 (BIRC3) are deleted, cells show NIK accumulation and constitutive p100 processing 29, 30 . cIAP1 is also degraded upon stimulation of melanoma cells with TWEAK, a TNF family member that activates alternative NF-kB signaling, leading to the suggestion that the first step in this pathway is receptor-induced cIAP degradation 34 . However, the exact roles of TRAF2, TRAF3 and cIAP1 and cIAP2 ('cIAP1-cIAP2') in CD40-or BAFF receptor (BAFF-R)-induced alternative NF-kB signaling remained unclear.
We now show that Traf2 À/À mice die postnatally and have lymphoid defects because of constitutive NIK signaling, just as do Traf3 À/À mice. Yet, despite their nearly identical phenotypes, TRAF2 and TRAF3 have distinct signaling functions. TRAF2 is required for cytokine-induced TRAF3 degradation that is dependent on cIAP1-cIAP2, which act as receptor-activated, TRAF3-directed ubiquitin ligases. Receptor-induced activation of cIAP1-cIAP2 depends on TRAF2, which acts as a Lys63-specific E3 for the cIAPs. TRAF3 itself is an adaptor that links a ubiquitin ligase complex consisting of TRAF2 and cIAP1-cIAP2 to NIK. We suggest that the first step in alternative NF-kB signaling triggered by CD40 or BAFF-R is TRAF2-dependent cIAP1-cIAP2 activation leading to TRAF3 degradation and disruption of the cIAP1-cIAP2-TRAF2-TRAF3-NIK complex.
RESULTS
Deletion of NIK prevents Traf2 À/À postnatal lethality The postnatal phenotypes of Traf2 À/À and Traf3 À/À mice are similar 31, 32 . Because TRAF3 deficiency has been proposed to cause postnatal lethality dependent on constitutive alternative NF-kB signaling that is rescuable by deletion of the Nfkb2 (ref. 25) , we examined whether TRAF2 ablation acts similarly and generated mice deficient in both TRAF2 and NIK. For comparison, we generated Traf3 À/À mice also deficient in NIK (Traf3 À/À Map3k14 À/À ). Deletion of only one Map3k14 allele prevented postnatal lethality and the runted stature of Traf2 À/À mice, similarly to the obligatory (we did not recover viable Traf3 À/À Map3k14 +/À mice in more than 50 crosses) deletion of both Map3k14 alleles in Traf3 À/À mice ( Fig. 1a and Supplementary Fig. 1a online). Reducing the NIK dosage also rescued splenic atrophy and reduction in splenocyte numbers ( Fig. 1b and Supplementary  Fig. 1b) . Serum cortisol concentrations, indicative of a stress response, were elevated in Traf2 À/À and Traf3 À/À mice, and deletion of NIK returned them to normal ( Supplementary Fig. 1c ). Several inflammatory chemokine mRNAs were also elevated in Traf2 À/À mouse embryonic fibroblasts (MEFs), but not to the same extent as in Traf3 À/À MEFs ( Supplementary Fig. 1d ). This suggests that the inflammatory response associated with TRAF2 deficiency was not as severe as the one associated with the TRAF3 deficiency, providing a plausible explanation for the dose-dependent effects of NIK in the two mutants.
Lymphoid abnormalities in TRAF2-and TRAF3-deficient mice Traf2 À/À and Traf3 À/À mice have many fewer CD4 + CD8 + doublepositive thymocytes 31, 32 . Although the mechanism underlying this defect is not clear, it could be related to elevated circulating cortisol in these mice and the known ability of glucocorticoids to induce thymocyte apoptosis 37, 38 . Deletion of NIK restored normal numbers of double-positive thymocytes in both Traf2 À/À and Traf3 À/À mice (Fig. 2a) .
Traf2 À/À and Traf3 À/À mice harbor elevated numbers of marginal zone B cells, and splenic B cells lacking TRAF2 or TRAF3 survive longer than wild-type cells [24] [25] [26] 39 , which should result in B cell accumulation and splenomegaly. However, Traf2 À/À and Traf3 À/À mice suffer from splenic atrophy and have many fewer splenocytes than wild-type mice 31, 32 . In both Traf2 À/À and Traf3 À/À mice, bone marrow B cell development was defective owing to impairment in the transition from the pro-B to the pre-B stage, characterized by CD19 expression (Fig. 2b ) resulting in fewer bone marrow B220 + cells. Expression of the mRNA for transcription factor Pax5, which regulates this transition 40 , was reduced in Traf2 À/À and Traf3 À/À B cells but was restored upon NIK deletion ( Fig. 2c) , which also rescued normal B cell development (Fig. 2b) . These defects are also consistent with the published effects of glucocorticoids on B cell progenitors 41 . Deletion of NIK prevented constitutive p100 processing in Traf2 À/À B cells (Fig. 2d) , as previously shown for Traf3 À/À B cells 25 . Consistent with the effect on p100 processing, deletion of NIK in either Traf2 À/À or Traf3 À/À mice reduced marginal zone B cell numbers and decreased splenic B cell survival to wild-type levels ( Supplementary  Fig. 2a ,b online).
Collectively, these results indicate that the absence of TRAF2 causes very similar lymphoid defects to those associated with TRAF3 ablation. Some of these defects are likely to be the direct consequence of constitutive NIK-dependent signaling, whereas others are probably caused by elevated serum cortisol.
TRAF2 deficiency and p100 processing TRAF2 negatively regulates p100 processing in B cells 24 . However, it was not clear whether TRAF2, like TRAF3 (ref. 27), also induces NIK proteasomal degradation. To investigate this point, we analyzed wild-type, Traf2 À/À and Traf3 À/À mouse embryonic fibroblasts (MEFs). Both Traf2 À/À and Traf3 À/À MEFs showed elevated NIK expression, constitutive p100 processing and nuclear p52 and RelB (Fig. 3a,b) . Map3k14 mRNA amounts were not substantially affected by ablation of either TRAF2 or TRAF3 ( Supplementary Fig. 3a online), suggesting that the observed changes in NIK expression are post-transcriptional. Notably, Traf3 À/À MEFs contained higher amounts of nuclear RelA than Traf2 À/À cells (Fig. 3a) , a finding that is consistent with the higher expression of NFkB-dependent inflammatory chemokines in these cells (Supplementary Fig. 1d ). As shown for TRAF3 (ref. 27 ), TRAF2 overexpression in human embryonic kidney (HEK)-293T cells induced proteasomedependent NIK degradation ( Fig. 3c and Supplementary Fig. 3b-d) . This activity was dependent on the N-terminal portion of TRAF2, which contains its RING finger; by contrast, deletion of the N-terminal RING finger of TRAF3 did not compromise its ability to induce NIK degradation, which is in contrast to a previous report that the RING finger of TRAF3 is essential for inhibition of alternative NF-kB signaling 42 (Fig. 3c) . Overexpression of either cIAP1 or cIAP2 also led to NIK degradation ( Supplementary Fig. 3c ).
TRAF3 recruits TRAF2 and cIAP2 to NIK TRAF2, TRAF3 and cIAP1-cIAP2 are all involved in rapid NIK turnover in unstimulated B cells, and their inactivation or deletion results in NIK accumulation and p100 processing 24, 25, 28, 29, 34 . Analyses of TRAF3 mutants in multiple myeloma 29, 30 suggest that TRAF3 binds to NIK and TRAF2, which is associated with cIAP1-cIAP2 (ref. 43 ). We examined the interaction of cIAP2, TRAF2 and TRAF3 with NIK in primary B cells. As endogenous NIK is of very low abundance, because of its rapid turnover in unstimulated cells, we incubated B cells with the proteasome inhibitor MG132 to prevent NIK degradation. Immunoprecipitation confirmed that NIK associates with cIAP2, TRAF2 and TRAF3 (Fig. 4a) . Depletion of TRAF3 by short hairpin RNA (shRNA)-mediated knockdown in BJAB human lymphoma cells prevented association of both TRAF2 and cIAP2 with NIK (Fig. 4b) . cIAP1-cIAP2-and TRAF2-dependent TRAF3 degradation Rapid NIK turnover in resting cells seems to be the main mechanism that prevents premature activation of alternative NF-kB signaling. However, how engagement of receptors that control B cell survival and development-for example, CD40 and BAFF-R-activates this pathway is not clear. It has been suggested that receptor-induced TRAF3 degradation is a critical regulatory step leading to NIK stabilization and p100 processing 26, 27 . However, a more recent report suggested that the first step is receptor-induced cIAP1-cIAP2 degradation 34 . We confirmed that CD40 or BAFF-R engagement resulted in rapid, proteasome dependent ( Supplementary Fig. 4a online) TRAF3 degradation that preceded p100 processing (Fig. 5a,b) . TRAF2 also decayed upon receptor activation, but not as extensively as TRAF3. Moreover, TRAF3 decay preceded TRAF2 decay ( Supplementary  Fig. 4b ). As expected, CD40 engagement also led to NIK stabilization that paralleled receptor-induced p100 processing ( Supplementary  Fig. 4c ). CD40-or BAFF-R engagement also resulted in extensive TRAF3 and modest TRAF2 decay, in cIAP1-and cIAP2-positive multiple myeloma cells only (Fig. 5c) . No significant cIAP2 decay was seen and neither TRAF2 nor TRAF3 were degraded in multiple myeloma cells lacking both cIAPs (Fig. 5c) . Similar results were seen upon treatment of primary B cells with a Diablo mimic that induces rapid cIAP1 and cIAP2 degradation 36 (Fig. 5d) . CD40-induced TRAF3 degradation also depended on TRAF2, whose absence in B cells and especially MEFs increased TRAF3 abundance ( Fig. 5e and Supplementary Fig. 5a online). TRAF3 deficiency, however, had no impact on TRAF2 amounts ( Supplementary Fig. 5b ).
Activation of cIAP2 E3 ligase activity toward TRAF3
To better understand the mechanism of receptor-induced TRAF3 degradation, we used HEK-293T cells stably expressing CD40 (HEK-293T-CD40). Expression of TRAF3 and either cIAP1 or cIAP2 in these cells resulted in TRAF3 degradation in a proteasome-dependent manner ( Fig. 6a and Supplementary Fig. 6 online) . We next examined whether CD40 engagement enhanced the E3 activity of cIAP2 and whether cIAP2 could directly ubiquitinate TRAF3. Flag-tagged wild-type or RING finger-mutated cIAP2 were transiently expressed in HEK-293T-CD40 cells. Hemagglutinin-tagged TRAF2 was also transiently expressed in a separate culture of HEK-293T-CD40 cells. After 48 h the cells were stimulated or not with antibody to CD40 (anti-CD40), and the cIAP2 and TRAF2 proteins were immunoprecipitated 2 h later. When incubated with recombinant glutathione-S-transferase (GST)-TRAF3 in an in vitro ubiquitination system 44 that contained ubiquitin, ATP, E1, and a mixture of E2s, wild-type cIAP2 but not RING finger-mutated cIAP2 led to TRAF3 polyubiquitination that was much more extensive if cIAP2 was isolated from CD40-stimulated cells (Fig. 6b) . The TRAF3 polyubiquitinating activity of cIAP2 was further enhanced by the presence of TRAF2 in the reaction mix. However, when TRAF2 was incubated in this reaction together with RING finger-mutated cIAP2, no TRAF3 ubiquitination was observed (Fig. 6b) , indicating that TRAF3 was not a direct substrate for the E3 ligase activity of TRAF2. Endogenous TRAF3 from CD40-stimulated B cells was polyubiquitinated, and this modification was inhibited by pretreatment of the CD40-stimulated cells with Diablo mimic (Supplementary Fig. 7 online) . The abundance of polyubiquitinated TRAF3 was augmented by treating the cells with a proteasome inhibitor, suggesting that the polyubiquitin chains were Lys48 linked. Accordingly, the polyubiquitinated form of TRAF3 found in CD40-stimulated cells did not react 
Anti-CD40 with an antibody that specifically recognizes Lys63-linked ubiquitin chains ( Supplementary Fig. 7 and ref. 23) .
Endogenous cIAP1 and cIAP2 immunoprecipitated from CD40-stimulated wild-type or TRAF3-deficient, but not from TRAF2-deficient, A20 mouse B cell line cells also showed enhanced E3 activity toward TRAF3 relative to cIAP1 and cIAP2 from unstimulated cells (Fig. 6c) . These results indicate that the E3 activity of cIAP1-cIAP2 toward TRAF3 is strongly stimulated upon CD40 engagement, in a TRAF2-dependent manner. As TRAF2 is also a ubiquitin ligase 13 and its RING finger is required for induction of NIK degradation, we examined whether TRAF2 is an E3 for cIAP2. Indeed, endogenous cIAP2 was subjected to Lys63-linked polyubiquitination in CD40-stimulated wild-type and TRAF3-deficient, but not in TRAF2-deficient, A20 cells (Fig. 6d) . In transfected HEK-293T cells expressing CD40, engagement of CD40 induced the Lys63-linked polyubiquitination of cIAP2, and this modification was strongly enhanced by coexpression of TRAF2, which also induced the Lys63-linked polyubiquitination of cIAP2 in unstimulated cells, an effect not seen upon expression of a RING finger deleted TRAF2 (Fig. 6e) . These results strongly suggest that TRAF2 is a Lys63-specific E3 ligase for cIAP2, whereas cIAP2 is Lys48-specific E3 ligase for TRAF3 (see model in Supplementary Fig. 8 online and Discussion).
DISCUSSION
The results described above indicate that although TRAF2 and TRAF3 are structurally similar RING finger proteins whose ablation results in constitutive activation of alternative NF-kB signaling, the biochemical roles they play in this pathway are distinct. Whereas TRAF3 acts as an adaptor that links an E3 ligase complex containing TRAF2 and cIAP1-cIAP2 to NIK in unstimulated cells, TRAF2 is required for receptor-induced activation of cIAP1-cIAP2, which act as Lys48-specific ubiquitin ligases that induce TRAF3 degradation. We propose that TRAF3 degradation is the first irreversible step committing the cell to activation of alternative NF-kB signaling. Receptor-induced TRAF3 degradation was observed previously and suggested to be responsible to NIK stabilization 27, 45 and for MAPK activation 23 . However, the mechanism of receptor (CD40 or BAFF-R)-induced TRAF3 degradation had remained elusive, and it had even been suggested that alternative NF-kB signaling is triggered by degradation of cIAP1-cIAP2, rather than by degradation of TRAF3 34 . However, in many experiments conducted with both normal B cells and B cellderived tumors, we reproducibly detected rapid and nearly complete, receptor-induced decay of TRAF3, partial TRAF2 degradation and hardly any cIAP1-cIAP2 degradation. We previously found that CD40 engagement results in rapid recruitment of a TRAF2-cIAP1-cIAP2 complex and TRAF3 to the receptor and that cIAP1-cIAP2 are required for receptor-induced TRAF3 degradation 23 . However, we did not examine in those studies whether receptor engagement activates cIAP1-cIAP2 ubiquitin ligase activity. The new results shown above demonstrate that CD40 occupancy stimulates the E3 activity of cIAP2 toward TRAF3, resulting in degradative, Lys48-linked polyubiquitination of TRAF3. CD40-induced cIAP1-cIAP2 activation correlated with their Lys63-linked polyubiquitination, and both effects were dependent on TRAF2. Thus, in addition to being an adaptor that recruits cIAP1-IAP2 and TRAF3 to the receptor, TRAF2 is also an E3 that activates cIAP1-cIAP2, most likely through their Lys63-linked ubiquitination. TRAF2, however, does not ubiquitinate TRAF3. These results provide the first, to our knowledge, demonstration of a ubiquitination cascade in which TRAF2 ubiquitinates and activates cIAP1-cIAP2, which then proceed to ubiquitinate TRAF3 (and to some extent TRAF2) and induce its degradation ( Supplementary  Fig. 8 ).
Unlike TRAF2, whose RING finger is required for cIAP1-cIAP2 activation and for NIK degradation, the RING finger of TRAF3 is dispensable for NIK degradation, supporting the conclusion that TRAF3 functions as an adaptor in this process and not as an E3. Although TRAF3, TRAF2 and cIAP1-cIAP2 are all engaged in degradative NIK polyubiquitination in unstimulated cells, we suggest that receptor occupancy results in recruitment of a pool of the complexes formed by these molecules to the receptor, where TRAF2 expression vectors and after 24 h were stimulated or not with anti-CD40 for 1 h. cIAP2 was immunoprecipitated using anti-Flag antibody, and its ubiquitination was analyzed with an antibody specific for Lys63-linked ubiquitin (HWA4C4). Exo., exogenous.
enhances cIAP1-cIAP2 E3 activity by ubiquitination and targets it toward TRAF3 (Supplementary Fig. 8 ). Once receptor-associated TRAF3 is degraded, NIK can no longer associate with the remaining cIAP1-cIAP2-TRAF2 complex. The absence of either TRAF2 or TRAF3 enhances the survival of B cells and their accumulation in the marginal zone, and we confirmed these results. However, we also found that ablation of either TRAF2 or TRAF3 resulted in a markedly defective development of bone marrow B cells with impaired transition from the CD19 À to CD19 + stage. In addition, Traf2 À/À and Traf3 À/À mice show thymic and splenic atrophy. Given the elevated concentration of circulating cortisol in these mice and the known lymphocidal activity of glucocorticoids 37, 38 , we presume that some of these defects are due to cortisol-induced killing of bone marrow B cell progenitors 37, 41 and thymocytes, as well as atrophy of lymphoid organs. However, the increased survival and accumulation of marginal zone B cells are most likely direct consequences of constitutive alternative NF-kB signaling in these mice, as this pathway drives B cell survival and accumulation in the marginal zone 46 . In support of this interpretation, a conditional deletion of TRAF3 using a CD19-driven cre transgene, which does not result in perinatal mortality and stress, leads only to increased B cell survival and accumulation of autoreactive marginal zone B cells 39 , a phenotype also produced by transgenic overproduction of BAFF, which results in prolonged activation of the alternative pathway 46 .
The perinatal lethality and stress-induced elevation in blood cortisol associated with TRAF3 ablation are due to uncontrolled activation of the alternative NF-kB pathway, as they are reversed by Nfkb2 ablation 25 . Our results indicate that the perinatal lethality caused by ablation of TRAF2 is also due to uncontrolled activation of this pathway. However, it should be noted that loss of TRAF3 results in a more profound elevation of NF-kB target gene transcription, some of which are likely to account for perinatal lethality and stress, than does the absence of TRAF2. Correspondingly, Traf3 À/À cells contain more RelA in their nuclei than Traf2 À/À cells. It is plausible that activation of RelA, a hallmark of classical NF-kB signaling, is partially due to autocrine production of TNF or a similar cytokine that signals to the classical IKK complex through TRAF2.
Collectively, our results indicate that TRAF2 and TRAF3 play essential and nonredundant roles in the alternative NF-kB pathway. As an adaptor, TRAF3 recruits a TRAF2-cIAP1-cIAP2 E3 complex to NIK, leading to its rapid turnover in resting cells. Upon CD40 or BAFF-R activation, TRAF2 ubiquitinates and activates cIAP1-cIAP2 to induce degradative Lys48-linked polyubiquitination of TRAF3. Degradation of TRAF3 prevents targeting of newly synthesized NIK by the TRAF2-cIAP1-cIAP2 ubiquitin ligase complex, allowing NIK accumulation and activation through autophosphorylation (Supplementary Fig. 8 ). This requirement for ongoing NIK synthesis explains the long delay in activation of alternative NF-kB signaling and its dependence on new protein synthesis.
METHODS
Mice. Traf2 +/À mice were obtained from Tak W. Mak; Traf3 +/À mice were from Hitoshi Kikutani and Map3k14 +/À (NIK-deficient) mice generated by Robert Schrieber were obtained from Amgen Inc; mice were intercrossed to generate the different strains used in the experiments described above. Mice were housed under conventional barrier protection according to UCSD and NIH guidelines, and mouse protocols were approved by the University of California San Diego Institutional Animal Care Committee.
Splenic B cell isolation and culture. Splenic single cell suspensions were prepared as described 47 . CD43 À B cells were isolated after removal of CD43 + cells with magnetic beads (Miltenyi) according to manufacturer's protocol.
B cells or B cell lines were stimulated with anti-CD40 (5 mg/ml; clone 3/23; Pharmingen), CD40L (500 ng/ml; PeproTech) or BAFF (200 ng/ml; PeproTech).
Flow cytometry. Single-cell thymus and spleen suspensions 47 were incubated with the indicated antibodies and analyzed on a FACScalibur flow cytometer using CellQuest software (Becton Dickinson). Fluorescein isothiocyanate-, phycoerythrin-or biotin-labeled antibodies to CD4, CD8, CD19, CD21, CD23 and CD45 (B220) were from Pharmingen. Biotinylated antibodies were detected by streptavidin-phycoerythrin (PharMingen).
Immunochemical procedures. MEFs, B cells and B cell lines were lysed in RIPA buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% (vol/vol) Nonidet P-40, 1% (wt/vol) deoxycholate, 1 mM PMSF) to prepare total lysates. Nuclear and cytoplasmic extracts were prepared as described 47 Short hairpin RNA, lentiviruses and transduction. A 5¢-AGAGTCAGGTTCC GATGAT-3¢ oligonucleotide directed against human TRAF3 was cloned into pLSLPw lentiviral vector, provided by Peter M. Chumakov 48 , and lentivirus was prepared and packaged as described 49 . Cells were transduced with lentivirus in the presence of 5 mg/ml polybrene (Sigma). After 24 h, the virus-containing medium was replaced with selection medium containing 5 mg/ml puromycin (EMD). After cell growth was stable, the cells were used in the experiments described.
In vitro ubiquitination assay. In vitro ubiquitination was performed as described 44 . HEK-293T cells stably expressing CD40 were transfected with pcDNA-HA-TRAF2 and with pcDNA-Flag-cIAP2 encoding wild-type or RING finger-mutated cIAP2 (provided by Zeev Ronai and John Reed, respectively). After simulation with anti-CD40, the cells were lysed and immunoprecipitated with anti-Flag or anti-hemagglutinin. Flag-cIAP2 was eluted from the protein G beads using 3x-Flag peptide (Sigma) and incubated with GST-TRAF3 produced in E. coli in the absence or presence of hemagglutinin-TRAF2 in a reaction mixture including ubiquitin, E1 and a mixture of E2 ubiquitinconjugating enzymes: UbcH2, UbcH3, Ubc5a, Ubc5b, Ubc5c, UbcH6, UbcH7 and UbcH10. Reactions were carried out at 30 1C for 30 min in 50 mM HEPES buffer, pH 7.8, containing 4 mM ATP and 10 mM MgCl 2 . GST-TRAF3 was immunoprecipitated, gel-separated, and analyzed by immunoblotting with anti-ubiquitin and anti-TRAF3. In other experiments, we used cIAP1 and cIAP2 isolated from unstimulated and stimulated A20 B cells. All subsequent incubations and procedures were as described above.
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